Company profile for Reneo Pharmaceuticals

NEW Drugs in Dev: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and ...
Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle function and preventing muscle injury, weakness and wasting. We are currently advancing a novel molecule into several diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
12230 El Camino Real, Suite 230 San Diego
Telephone
Telephone
+1 858-283-0280
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/10/04/2958522/0/en/OnKure-Announces-Closing-of-Merger-with-Reneo-Pharmaceuticals-and-Concurrent-Private-Placement-of-65-Million.html

GLOBENEWSWIRE
04 Oct 2024
Reneo Shareholders Approve OnKure Merger
Reneo Shareholders Approve OnKure Merger

03 Oct 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/10/03/2957405/0/en/Reneo-Pharmaceuticals-Announces-Stockholder-Approval-of-Merger-with-OnKure.html

GLOBENEWSWIRE
03 Oct 2024

https://www.globenewswire.com/news-release/2024/08/13/2929098/0/en/Reneo-Pharmaceuticals-Reports-Second-Quarter-2024-Financial-Results.html

GLOBENEWSWIRE
13 Aug 2024

https://www.globenewswire.com/news-release/2024/05/13/2880338/0/en/Reneo-Pharmaceuticals-and-OnKure-Announce-Proposed-Merger.html

GLOBENEWSWIRE
13 May 2024

https://www.fiercebiotech.com/biotech/onkure-hitches-reneos-ride-nasdaq-65m-pipe-boot

Max Bayer FIERCE BIOTECH
13 May 2024

https://www.globenewswire.com/news-release/2024/05/07/2876624/0/en/Reneo-Pharmaceuticals-Reports-First-Quarter-2024-Financial-Results.html

GLOBENEWSWIRE
07 May 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty